Table 2

Adverse events related to sibrotuzumab

Treatment at onset
5 mg/m210 mg/m225 mg/m250 mg/m2Total
n%n%n%n%n%
Summary data
Total number of patients710061006100710026100
Total with any adverse event related to sibrotuzumab114233117229623
Adverse events
 Anorexia1 (1)1414
 Flushing1 (1)a141 (1)171 (1)171 (1)14415
 Back pain1 (3)1414
 Fever1 (2)1414
 Rigors1 (2)141 (1)171 (2)172 (2)29519
 Hypertension1 (1)171 (2)1428
 Coughing1 (2)1714
 Dyspnea1 (2)1714
 Hypoxia1 (1)1414
  • a Figure in parentheses indicates CTC grade for adverse event.